PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K

What Happened

• Pacific Biosciences of California, Inc. (PACB) announced its financial results for the fourth fiscal quarter and full year ended December 31, 2025. The company issued a press release dated February 12, 2026 that contains the results; that release is attached to the Form 8‑K as Exhibit 99.1. The disclosure was furnished under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Announcement date: February 12, 2026.
• Reporting period: fourth quarter and full year ended December 31, 2025.
• Press release title and exhibit: “PacBio Announces Fourth Quarter and Full Year 2025 Financial Results,” attached as Exhibit 99.1 to the Form 8‑K.
• The press release was furnished (not filed) with the SEC via this Form 8‑K.

Why It Matters

• This 8‑K provides PACB’s latest earnings disclosure (quarterly results and full‑year results), which is a primary driver of short‑term stock moves and an important data point for assessing the company’s recent revenue and financial performance.
• Retail investors should read the attached press release (Exhibit 99.1) for the specific revenue, profit/loss, and any commentary or guidance the company provided, and compare those figures to prior quarters and analyst expectations.